JOURNEY MEDICAL CORPORATION - COMMON STOCK

Journey Medical Corporation Appoints Michael C. Pearce to Board of Directors

11 7 2024 15:05:39 提供 Nasdaq GlobeNewswire

Journey Medical Corporation to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company Showcase

15 5 2024 15:01:52 提供 Nasdaq GlobeNewswire

Journey Medical Corporation Reports First Quarter 2024 Financial Results and Recent Corporate Highlights

13 5 2024 15:01:47 提供 Nasdaq GlobeNewswire

Journey Medical Corporation to Announce First Quarter 2024 Financial Results on May 13, 2024

07 5 2024 07:30:10 提供 Nasdaq GlobeNewswire

Journey Medical Corporation Appoints Joseph Benesch as Chief Financial Officer

01 5 2024 15:01:30 提供 Nasdaq GlobeNewswire

Journey Medical Corporation to Present at the Planet MicroCap Showcase: Vegas 2024

25 4 2024 07:30:48 提供 Nasdaq GlobeNewswire

Journey Medical Corporation Reports Full-Year 2023 Financial Results and Recent Corporate Highlights

21 3 2024 15:01:27 提供 Nasdaq GlobeNewswire

Journey Medical Corporation Announces U.S. FDA Acceptance of New Drug Application for DFD-29 for the Treatment of Rosacea

18 3 2024 07:30:30 提供 Nasdaq GlobeNewswire

Journey Medical Corporation to Announce Year End 2023 Financial Results on March 21, 2024

15 3 2024 07:30:01 提供 Nasdaq GlobeNewswire

Journey Medical Corporation to Participate in the 36th Annual ROTH Conference

13 3 2024 07:30:14 提供 Nasdaq GlobeNewswire

Journey Medical Corporation Submits New Drug Application to FDA for DFD-29 to Treat Rosacea

05 1 2024 07:30:12 提供 Nasdaq GlobeNewswire

Journey Medical Corporation Secures Credit Facility with SWK Holdings for up to $20 Million

02 1 2024 15:05:30 提供 Nasdaq GlobeNewswire

Journey Medical Corporation Announces Successful Completion of Pre-NDA Meeting with the FDA for DFD-29 to Treat Rosacea

06 12 2023 07:00:51 提供 Nasdaq GlobeNewswire

Journey Medical Corporation Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights

07 11 2023 15:01:18 提供 Nasdaq GlobeNewswire

Journey Medical Corporation to Announce Third Quarter 2023 Financial Results on November 7, 2023

31 10 2023 07:30:12 提供 Nasdaq GlobeNewswire

Journey Medical Corporation Announces Data from Bioavailability Study of DFD-29 (Minocycline Hydrochloride Modified Release Capsules, 40 mg) vs. Solodyn® (Minocycline Hydrochloride Extended-Release Tablets, 105 mg)

20 10 2023 07:30:59 提供 Nasdaq GlobeNewswire

Journey Medical Corporation Enters into an Exclusive License Agreement with Maruho Co., Ltd. for Qbrexza® in South Korea and Other Asian Nations

06 9 2023 07:00:04 提供 Nasdaq GlobeNewswire

Journey Medical Corporation Reports Second Quarter 2023 Financial Results and Recent Corporate Highlights

08 8 2023 15:01:33 提供 Nasdaq GlobeNewswire

Journey Medical Corporation to Announce Second Quarter 2023 Financial Results on August 8, 2023

02 8 2023 15:01:42 提供 Nasdaq GlobeNewswire

Journey Medical Corporation to Announce Second Quarter 2023 Financial Results the Week of August 7, 2023

19 7 2023 07:30:00 提供 Nasdaq GlobeNewswire